scispace - formally typeset
Q

Qiangrong Liang

Researcher at New York Institute of Technology College of Osteopathic Medicine

Publications -  56
Citations -  8955

Qiangrong Liang is an academic researcher from New York Institute of Technology College of Osteopathic Medicine. The author has contributed to research in topics: Autophagy & Mitophagy. The author has an hindex of 32, co-authored 48 publications receiving 7664 citations. Previous affiliations of Qiangrong Liang include San Francisco VA Medical Center & University of Cincinnati.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.

TL;DR: A direct functional role for GATA4 and GATA6 as regulators of cardiomyocyte hypertrophic growth and gene expression is demonstrated and it is demonstrated that cardiac-expressed GATA factors are necessary mediators of this process.
Journal ArticleDOI

The Transcription Factor GATA4 Is Activated by Extracellular Signal-Regulated Kinase 1- and 2-Mediated Phosphorylation of Serine 105 in Cardiomyocytes

TL;DR: A molecular pathway whereby MEK1-ERK1/2 signaling regulates cardiomyocyte hypertrophic growth through the transcription factor GATA4 by direct phosphorylation of serine 105, which enhances DNA binding and transcriptional activation is suggested.
Journal ArticleDOI

Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter

TL;DR: An efficient, experimentally flexible system that enables us to reversibly affect both abundant and nonabundant cardiomyocyte proteins is developed and appears to be robust and can be used to temporally control high levels of cardiac-specific transgene expression.